期刊文献+

多层螺旋CT评估肝癌射频消融术后肿瘤灭活的临床价值 被引量:10

Research on the clinical value of tumor deactivation after radiofrequency ablation of liver cancer assessed by MDCT
下载PDF
导出
摘要 目的:探讨多层螺旋CT评估肝癌射频消融(RFA)术后肿瘤灭活的临床价值。方法:采用CT灌注成像(CTP)联合CT动脉成像(CTA)及CT增强扫描评价91例肝癌患者行RFA术治疗前后肿瘤的大小、密度变化及凝固性坏死区范围,比较两种评价方法诊断肿瘤复发或残余的灵敏度、特异度和准确率。结果:CTP联合CTA诊断肿瘤复发或残余的灵敏度、特异度和准确率分别为100%、95.3%和96.2%;常规增强CT分别为33.3%、88.4%和78.8%。RFA治疗后肿瘤复发或残余的诊断灵敏度、准确率CTP联合CTA高于常规增强CT,差异有统计学意义(x^2=6.912,x^2=7.121;P<0.05);特异度之间两者差异无统计学意义(x^2=0.615,P>0.05)。结论:CTP联合CTA可准确地判断RFA后肿瘤有无灭活及程度,且优于常规增强CT,是RFA有效与否的有效评估方法,具有较高临床价值。 Objective: To explore the clinical value of tumor deactivation after radiofrequency ablation of liver cancer assessed by MDCT. Methods: By CT perfusion combined with CT angiography and CT enhanced scan in 91 cases of liver cancer patients before and after radiofrequency ablation treatment, the change of tumor size, density change, scope of coagulation necrosis area and comparison sensitivity, specificity and accuracy of two methods diagnosis of recurrent or residual tumor were observed. Results: In the diagnosis of tumor recurrence or residual degree of sensitivity, specificity and accuracy CTP combine CTA were 100%, 95.3%, 96.2%, conventional enhanced CT were 33.3%, 88.4% and 78.8%. The diagnosis of recurrence or residual tumor after radiofrequency sensitivity and accuracy CTP combine CTA is higher than conventional enhancement CT, The difference was statistically significant(x2=6.912, x2=7.121; P〈0.05). Both no statistical difference between specificity(x2=0.615, P〈0.05).Conclusion: CTP combination CTA can accurately determine the tumor after radiofrequency ablation for inactivated and degree, and superior to the conventional enhanced CT, is an effective evaluation method of radiofrequency ablation with a high clinical value.
作者 刘玉海
出处 《中国医学装备》 2016年第2期77-80,共4页 China Medical Equipment
关键词 体层摄影术 X射线计算机 肝癌细胞 射频消融 肿瘤灭活 Tomography, X-ray computer Hepatocellular carcinoma Radiofrequency ablation lhmor deactivation
  • 相关文献

参考文献16

  • 1Blechacz B,Mishra L. Hepatocellular carcinoma biology[J].Recent Results Cancer RasRes, 2013, 190: 1-20.
  • 2Raut CP,Lzzo F,Marra P,et al.Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis[J].Ann Surg Oncol, 2005,12(8).616-628.
  • 3陈敏华,严昆,杨薇,高文,戴莹,王艳滨,张晖,霍苓,邢宝才,黄信孚.343例肝恶性肿瘤射频消融疗效及并发症[J].北京大学学报(医学版),2005,37(3):292-296. 被引量:64
  • 4中国抗癌协会肝癌专业委员会中国抗癌协会临床肿瘤学协作委员会.肝癌射频消融治疗规范的专家共识.中华医学会肝病学分会肝癌学组临床肝胆病杂志,2011,27(3):236-244.
  • 5陈敏华,刘吉斌,严昆,武金玉,霍苓,杨仁杰,张晓鹏,黄信孚.超声引导射频消融治疗肝脏恶性肿瘤[J].中华超声影像学杂志,2001,10(7):404-407. 被引量:79
  • 6Livraghi T,Goldberg SN,Lazzaroni S,et at. Small hepatocellular carcinoma.treatment with radiofrequency ablation versus ethanol injection[J]. Radiology, 1999,210(3): 655-661.
  • 7Francica G,Marone G.Ultrasound guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hypertbermia with a cooled-tip needle' .a preliminary clinical experience[J].Eur J Ultrasound Eur J Ultrasound, 1999,9(2): 145 -153.
  • 8Meloni MF,Goldberg SN,Livraghi T,et al. Hepatocellular carcinoma treated with rada'ofrequency ablation:comparison of pulse inversion contrast- enhanced harmonic sonography,contrast-enhanced power dopple sonography,and helical CT[J].Am J Poentgenol, 2001,177(2): 375-380.
  • 9Vilgrain V.Multidetector CT and MRI of malignant liver tumors[J]. J Radiol,2003,84(4) :459-470.
  • 10Fujimoto K, Tonan T, Azuma S,et al. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C :correlation with pathologic fibrosis stage and inflammatory activity grade[J].Radiology,2011, 258(1): 739-748.

二级参考文献29

共引文献175

同被引文献85

引证文献10

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部